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Abstract: There is growing evidence that omega-3 (n-3) polyunsaturated fatty-acids (PUFAs) are 
important for the brain development in childhood and are necessary for an optimal health in adults. 
However, there have been no studies examining how the n-3 PUFA composition of human milk 
influences infant behavior or temperament. To fill this knowledge gap, 52 breastfeeding mothers 
provided milk samples at 3 months postpartum and completed the Infant Behavior Questionnaire 
(IBQ-R), a widely used parent-report measure of infant temperament. Milk was assessed for n-3 
PUFAs and omega-6 (n-6) PUFAs using gas-liquid chromatography. The total fat and the ratio of n-
6/n-3 fatty acids in milk were also examined. Linear regression models revealed that infants whose 
mothers’ milk was richer in n-3 PUFAs had lower scores on the negative affectivity domain of the 
IBQ-R, a component of temperament associated with a risk for internalizing disorders later in life. 
These associations remained statistically significant after considering covariates, including maternal 
age, marital status, and infant birth weight. The n-6 PUFAs, n-6/n-3 ratio, and total fat of milk were 
not associated with infant temperament. These results suggest that mothers may have the ability to 
shape the behavior of their offspring by adjusting the n-3 PUFA composition of their milk. 
Keywords: breastfeeding; breast milk; temperament; fatty acids; LC-PUFA; omega-3; omega-6; 
DHA; AA; children; early life nutrition 
 
1. Introduction 
Early life nutrition plays a foundational role in brain development [1–3]. In recent decades, 
research has shown that exposure to human milk and the variation in its composition contribute 
meaningfully to children’s behavior, cognition, and disease risk [4–6]. The American Academy of 
Pediatrics recommends that human milk be the sole source of infant nutrition for the first 6 months 
of life [7], a sensitive period characterized by rapid brain development [2,3]. One key nutritional 
factor that is present in human milk and that is necessary for an optimal brain development during 
this period are omega-3 (n-3) polyunsaturated fatty-acids (PUFAs) [8,9].  
Human milk contains relatively high levels of n-3 PUFAs, which are essential to visual, motor, 
and cognitive development [8,9]. Among the 11 n-3 PUFAs, the three most important and prevalent 
in human milk are alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic 
acid (DHA) [5,10]. ALA is the most common n-3 PUFA in human milk [10] (and the adult diet) and 
can be converted into EPA and DHA [11]. DHA is the most abundant n-3 PUFA in the central nervous 
system in mammals and forms the structural matrix of grey matter and retinal membranes [9,12]. 
EPA is used to produce eicosanoids, signaling molecules that play numerous roles, including 
reducing inflammation in the body and the brain [13,14]. The U.S. Department of Health and Human 
Services 2015−2020 Dietary Guidelines for Americans recommend that all adults, particularly 
pregnant and breastfeeding women, consume 8 ounces of seafood per week, providing 
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approximately 250 mg of EPA and DHA per day [15]. Breast-fed infants have significantly higher 
levels of n-3 PUFAs in their plasma lipids at three months than do infants given formula lacking n-3 
fortification [16]. An autopsy study showed that the rate of accumulation of DHA is approximately 
5.0 mg a day in the brains of breast-fed infants versus 2.3 mg a day in infants fed non-DHA fortified 
formula [17]. 
Numerous studies have shown that deficiencies in n-3 PUFAs are related to mood and anxiety 
disorders [18,19]. In adults, n-3 supplementation has benefits for the prevention and treatment of 
major depression [20], bipolar disorder [21], and anxiety disorders [22]. Much less is known about 
how early variations in the exposure to n-3 PUFAs impact the mood and behavior of children. 
However, animal models suggest that early n-3 exposure can have a lasting impact on offspring 
temperament and behavioral phenotypes. For example, feeding pregnant rats diets deficient in n-3 
PUFAs increases anxiety-like behavior in rat pups, and upregulates anxiogenic-related glucocorticoid 
receptors in the frontal cortex, hypothalamus, and hippocampus [23]. These pre-clinical studies are 
consistent with correlational studies in human children. For example, in a diverse study of 255 
women, eating a diet higher in n-3 relative to n-6 fatty acids during pregnancy buffered Black infants 
against the detrimental effects of maternal stress on infant regulatory capacities [24]. Plasma DHA 
levels have also been found to negatively correlate with depressive symptoms in children and 
adolescents with bipolar disorder [25]. 
No studies, however, could be found examining whether the n-3 PUFA composition of milk 
influences the infant mood or anxiety in humans, although several studies have linked cortisol levels 
in milk to infant temperament [26–28]. For example, one study showed that higher levels of cortisol 
in milk predicted an enhanced performance on the autonomic stability cluster on the Neonatal 
Behavioral Assessment Scale in neonates [27]. Studies have also found that cortisol levels in mothers’ 
milk are positively correlated with a negative affectivity and fear reactivity in humans [26,28]. Most 
of what we know about lactational programing comes from animal models, and findings are 
generally consistent with the notion that milk is an important early moderator of the infant phenotype 
[29–31]. For example, in a study of Rhesus Macaques, heavier mothers with more reproductive 
experience were able to supply more calories to their infant through milk [32]. Moreover, infants 
whose mothers supplied more calories through milk in the early postnatal period showed higher 
activity levels and a greater confidence in a stressful setting later in infancy [32]. In sum, research has 
neglected the question of whether the fatty acid composition of milk influences infant temperament 
in humans. 
To fill this gap, the current study tests whether the n-3 PUFA composition of mothers’ milk is 
associated with the temperament of their infants. To address this question, milk samples were 
collected from 52 mothers of 3-month old infants and assessed for n-3 PUFA levels using gas-liquid 
chromatography. Mothers also completed the Rothbart Revised Infant Behavior Questionnaire (IBQ-
R) [33], a widely-used parental-report instrument that assesses three broad dimensions of infant 
temperament (negative affectivity, orienting/regulation, and surgency/extraversion). Given that n-3 
PUFAs and higher n-3/n-6 ratios have been found to be protective against mood disorders and 
anxiety symptoms [20], we predicted that n-3 PUFAs and the n-3/n-6 ratio in milk would be inversely 
correlated with the negative affectivity dimension of the IBQ-R. n-3 PUFAs have also been linked to 
enhanced executive functioning in children [9]. Therefore, we predicted that milk n-3 PUFAs levels 
would be positively correlated with scores on the orienting/regulation temperament dimension. We 
had no predictions regarding the surgency/extraversion temperament dimension. Exploratory 
analyses are also presented; they test whether the levels of n-6 PUFAs, total PUFAs or total milk fat 
concentrations are associated with infant temperament. 
2. Methods 
2.1. Participants 
Fifty-two breastfeeding mothers and their three-month-old infants were enrolled in a large 
longitudinal study of early development from a medical center in Southern California. To be eligible 
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to participate in the study, participants had to be over the age of 18, English-speaking, with a 
singleton intrauterine pregnancy. Women were ineligible for this study if they used alcohol, tobacco, 
illicit drugs, had cervical or uterine abnormalities, used medications that impacted the endocrine 
function, had a diagnosis of a disease influencing the neuroendocrine function, or had an infant 
admittance to the Neonatal Intensive Care Unit at birth because of compromised health (e.g., 
intrauterine growth restriction and respiratory distress syndrome). 
After mothers gave informed consent to participate in the study, they were asked to come into 
the laboratory at 3 months postpartum (M = 3.01 months, SD = 0.25) to provide milk samples and fill 
out a survey regarding their infants’ temperament. This study was approved by the Institutional 
Review Board at the University of California, Irvine (ethics approval code HS# 2002−2441, first 
approved: January 31, 2003; renewed most recently: February 25 2019). 
2.2. Determination of Milk Fatty Acid Levels 
Mothers were asked to empty the contents of one breast with an electric breast pump into a 
sterile plastic container (Medela, Inc., McHenry, IL, USA). In an effort to ensure that the mother’s 
milk donation for the study would not adversely impact infant nutrition, providing milk samples 
was made an optional part of this larger longitudinal study, and mothers were only asked to empty 
the contents of one breast, leaving milk in the other breast for the infant. Before the collection, the 
mothers were asked to clean the breast and nipple area with an antibacterial wipe and wait until the 
area dried (to leave open the possibility to examine the microbial composition of the milk for later 
research). The milk samples were then immediately aliquoted into polypropylene tubes and stored 
at 70 °C until they were assessed for fatty acids. The time of day of the milk collection was recorded 
and modestly correlated with the n-3 fatty acid composition of the milk (Pearson’s r = −0.344, p = 
0.015). The time of day of the sample collection was not related to any of the other fatty acids’ 
composite variables (Pearson’s r ranged from −0.175 to −0.008; ps > 0.153). 
The fatty acid composition of the breast milk was analyzed by gas-liquid chromatography in 
prepared fatty acid methyl esters. The total lipids were extracted from the milk by a method described 
previously [34], using tridecanoin as the internal standard [35]. The thawed milk samples were 
shaken vigorously and saponified in 6% ethanolic KOH for 1 h at 37 °C. The mixture was extracted 
twice with hexane (20 min on rotator), and spun to separate the phases. The hexane layers were then 
combined and evaporated under a gentle stream of nitrogen to reduce lipid peroxidation. The fatty 
acid methyl esters were prepared by heating the reconstituted samples in 12% boron trifluoride-
methanol for 10 min at 100 °C in tightly sealed tubes. The derivatized samples were separated with a 
Hewlett-Packard gas chromatograph equipped with an Omegawax 250 capillary column and 
isothermal oven.  
The total of the n-3 PUFAs was computed by summing the total fats from ALA, EPA, DHA, and 
a rare n-3 PUFA detected in milk, Eicosatrienoic acid (ETE). The total of the n-6 fatty acids was 
computed by summing the total fats from Linolelaidic acid, Arachidic acid, Linoleic acid, Linolenic 
acid, Dihomo-gamma-linolenic acid (DGLA), Arachidonic acid (AA), and Eicosadienoic Acid. The n-
6/n-3 PUFA ratio was computed by dividing the total fats from n-6 PUFAs by the total fats from n-3 
PUFAs. Higher ratios represent milk that has more n-6 fatty acids relative to n-3s. The total PUFA 
concentration in milk was determined by summing the levels of n-3 and n-6 PUFAs. 
2.3. Infant Temperament 
To assess the infant temperament, mothers were asked to fill out the Rothbart Revised Infant 
Behavior Questionnaire (IBQ-R) during their laboratory visit [33]. The IBQ-R includes 191 specific 
questions addressing concrete behaviors such as, “During a peek-a-boo game, how often did the baby 
smile?” and “How often during the last week did the baby startle to a sudden or loud noise?” To 
prevent errors in recall, the scale only asks mothers about recently occurring events, using a 7-point 
Likert scale (1-never to 7-always). The IBQ-R measures three broad dimensions of temperament: 
negative affectivity, surgency/extraversion, and orienting/regulation. The negative affectivity 
dimension is created by averaging the scores across four subscales assessing infant sadness, fear, 
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falling reactivity, and distress to limitations. The orienting/regulation dimension is created by 
averaging across four subscales of mothers’ ratings of infants’ cuddliness/affiliation, low intensity 
pleasure, duration of orienting, and soothability. The surgency/extraversion dimension is a 
composite averaged from six subscales assessing infant approach, vocal reactivity, high intensity 
pleasure, smiling and laughter, activity level, and perceptual sensitivity. This widely used parental-
report instrument has been shown to be reliable across parental reports [33] and to correlate well with 
behavioral observations of infants [36]. The IBQ-R has been validated for use for infants aged 3 to 12 
months, scores are relatively stable over the first year of life [36], and the scale takes approximately 
30 min to complete [33]. As part of the larger longitudinal study, mothers also completed the IBQ-R 
at 6 months. See Table S1 in the supplemental materials for exploratory analyses testing the 
association between the milk fatty acid composition at 3 months and the infant temperament at 6 
months.  
2.4. Demographic and Health Information 
Various demographic and health measures were tested as potential covariates. Maternal reports 
of race/ethnicity, age, education level, income, parity, marital status, and breastfeeding exclusivity 
were collected during a structured interview. A medical record review was conducted to assess the 
birth outcomes, including the infant sex, gestational age at delivery, and birth weight and length. The 
early pregnancy BMI (at 15 weeks) and weight gain during pregnancy (weight in pounds at 37 weeks-
15 weeks) were collected during laboratory visits as part of the larger longitudinal study. At 3 
months, the infant weight was assessed using a digital scale (Midmark, Versailles, OH, USA), and 
the height was determined while the child lay in a supine position. The child BMI percentiles (BMIP) 
at birth and 3 months were calculated using an SPSS macro that fits the child’s height and weight to 
standard WHO growth curves and generates a child’s BMI z-score standardized for age and sex 
[37,38]. For ease of interpretation, these z-scores were converted to percentiles.  
2.5. Statistical Analysis Strategy 
First, preliminary analyses were performed to check that the variables were normally 
distributed. Outliers that were greater than 3 standard deviations above or below the mean were 
winsorized to bring them to within 2 standard deviations before the analysis. We planned to log-
transform any skewed variables; however, after winsorization, all variables were normally 
distributed. Second, we sought to identify potential confounds by testing whether demographic or 
health characteristics were associated with fatty acid concentrations in milk. Linear regression models 
were run with various demographic (age, income, education, marital status, race/ethnicity and infant 
sex) and health (maternal BMI, weight gain in pregnancy, gestational age at birth, exclusive 
breastfeeding status, and infant BMIP at birth and at 3 months) covariates entered simultaneously to 
predict n-3, n-6, n-6/n-3 ratios, and the total milk fat. Demographic or health variables that were 
associated with any one of the milk fatty acid composite variables with a p-value < 0.10 were included 
as covariates in the subsequent analysis. For the primary analysis, a multivariate linear regression 
was used to test whether the n-3, n-6, n-6/n-3 ratios, total PUFAs, or total milk fat predicted the 
negative affectivity or orienting/regulation dimension of the IBQ-R, adjusting for potential 
confounds. We also ran an exploratory analysis to see whether the fatty acid composition of milk was 
associated with the surgency/extraversion factor. If there was a significant association, we then used 
a follow-up linear regression analysis to test: (i) which specific sub-scales that made up the IBQ-R 
temperament dimension were significantly related to the fatty acid composite, and (ii) which specific 
fatty acid type (e.g., DHA vs. ALA) predicted the IBQ-R temperament dimension. Finally, we tested 
whether infant sex or exclusive breastfeeding moderated any observed significant association 
between the fatty acid levels and IBQ-R dimension. A moderation analysis was carried out by 
creating cross products between the potential moderator (infant sex, exclusive breastfeeding) and 
fatty acid levels, and the cross-products were then included in a linear regression model with the 
constituent variables and covariates. All analyses were performed in SPSS version 21.0. The findings 
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were considered statistically significant if the p-values were under 0.05. The effect sizes (Standardized 
Betas or β) are also provided for all analyses, regardless of the significance level.  
3. Results 
3.1. Preliminary and Descriptive Analyses 
The demographic and health information of the samples is presented in Table 1. The fatty acids 
composition of the milk samples are presented in Table 2. Several milk samples were more than three 
standard deviations higher than the mean in terms of n-3 PUFA levels (n = 1), EPA levels (n = 2), ALA 
levels (n = 1), and ETE levels (n = 1) and were winsorized to within 2 standard deviations of the mean 
before the statistical analysis. 
Table 1. Sample characteristics and their association with the fatty acid composition of the milk. 
 Mean/% 
Standard 
Deviation 
Range Omega-3 Omega-6 
Omega-6/3 
Ratio 
Total Fat 
    Stand. β Stand. β Stand. β Stand. β 
Maternal 
Characteristics 
       
Maternal age  29.67 4.86 19.2–39.9 0.407 t 0.285 −0.066 0.254 
Education  2.70 1.051 0−4 0.113 −0.014 −0.167 −0.060 
Household Income 69,489 33,980 25k–105k 0.008 −0.186 −0.286 −0.181 
Pre-Pregnancy BMI  24.17 5.98 16.4–47.4 −0.102 −0.086 −0.045 −0.026 
Pregnancy Weight 
Gain (lbs) 
35.60 13.27 9.00–71.00 0.103 0.221 0.168 0.243 
Parity (% 
Primiparous) 
48.1%  1−4 0.085 −0.053 −0.123 −0.076 
Exclusive 
Breastfeeding 
63.27%   0.133 0.168 0.027 0.260 
% Married 75%   −0.223 0.341 0.593 * 0.223 
Race/Ethnicity        
% White  58.3%       
% Latina  18.8%   0.006 0.118 0.117 0.220 
% Asian 10.4%   0.057 −0.006 −0.052 0.015 
% Multi-
Ethnic/Other 
12.5%   −0.152 −0.011 0.170 −0.145 
Infant 
Characteristics  
       
Birth Weight 
(grams) 
3465.49 386.874 2470–4220 0.104 0.405 0.449 t 0.215 
Gestational Age at 
Birth (weeks) 
39.6822 1.12 37.1–42.3 −0.093 −0.070 0.090 −0.147 
BMIP at Birth 56.92% 0.30 0.34–98% −0.114 −0.125 −0.175 −0.164 
BMIP at 3 mos 46.25% 0.27 0.02–97% 0.164 0.101 −0.034 −0.013 
% Female Infants 48%   0.117 0.181 0.035 0.120 
Note: Race/ethnicity was dummy coded to create contrasts to compare Hispanic, Asian, and Multi-
Ethnic/Other groups to whites. Married was coded as 1 = Married, 0 = Not married; Infant sex was 
coded as Female = 2, Male = 1. Bolded coefficients indicate those with p-values < 0.10 = t and p-values 
< 0.05 = *. BMIP = Body Mass Index Percentile. 
Table 2. Milk fatty acid concentrations. 
 IUPAC Name Mean 
Standard 
Deviation 
Range 
  (ug/mL) (ug/mL) (ug/mL) 
Omega-3 Fatty Acids     
Linolenic acid (ALA) 
(9Z,12Z,15Z)-octadeca-9,12,15-
trienoic acid 
13.80 6.15 
4.26–
42.25 
Eicosatrienoic acid (ETE) 
(11Z,14Z,17Z)-icosa-11,14,17-
trienoic acid 
0.74 1.02 0.02–7.00 
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Eicosapentaenoic acid (EPA) 
(5Z,8Z,11Z,14Z,17Z)-icosa-
5,8,11,14,17-pentaenoic acid 
1.09 1.16 0.06–7.00 
Docosahexaenoic acid (DHA)  
(4Z,7Z,10Z,13Z,16Z,19Z)-
docosa-4,7,10,13,16,19-
hexaenoic acid 
2.72 1.91 
0.77–
10.71 
Omega-6 Fatty Acids     
Linolelaidic acid  
(9E,12E)-octadeca-9,12-dienoic 
acid 
1.16 0.30 1.00–3.08 
Arachidic acid  (113C)icosanoic acid 194.60 72.78 
65.12–
398.72 
Linoleic acid  
(9Z,12Z)-octadeca-9,12-dienoic 
acid 
0.54 .06 0.51–0.89  
Linolenic acid  
(9Z,12Z,15Z)-octadeca-9,12,15-
trienoic acid 
2.26 1.71 0.14–8.79 
Dihomo-gamma-linolenic acid  
(DGLA) 
(8Z,11Z,14Z)-icosa-8,11,14-
trienoic acid 
5.41 2.21 
1.41–
10.55 
Arachidonic acid (AA)  
(5Z,8Z,11Z,14Z)-icosa-
5,8,11,14-tetraenoic acid 
1.17 0.94 0.12–4.92 
Eicosadienoic Acid 
(11E,14E)-icosa-11,14-dienoic 
acid 
3.72 1.78 1.04–9.01 
Composite Fatty Acid Variables     
Total Omega-3   18.36 7.98 
6.66–
55.64 
Total Omega-6  208.85 77.88 
70.11–
433.86 
Omega-6/Omega-3 Ratio  12.12 4.36 
4.86–
27.14 
Total Milk PUFAs  227.21 83.57 
83.58−489
.50 
Total Milk Fat  942.51 346.76 398–2301 
See Table 1 for the results of the linear regression analysis testing for associations between 
sociodemographic and health factors and the milk fatty acid composition. Married mothers had 
significantly higher n-6/n-3 ratios in their milk than mothers who were not married (p = 0.010). Older 
mothers tended to have higher levels of n-3 PUFAs in their milk (p = 0.060). Babies with a higher birth 
weight also tended to have higher n-6/n-3 ratios in their milk (p = 0.086). Infant sex, gestational age at 
delivery, and infant BMIP at birth or 3 months were not associated with the milk fatty acid 
composition. Likewise, mothers’ pre-pregnancy BMI, weight gain in pregnancy, income, education, 
exclusive breastfeeding status, parity and race/ethnicity did not predict fatty acid levels in milk. 
Therefore, only the maternal age, marital status, and infant birth weight were included as covariates 
in the subsequent linear regression models.  
The average infant score on the surgency/extraversion factor was 3.92 (SD = 0.88), the negative 
affectivity factor was 2.99 (SD = 0.56), and the orienting regulation factor was 5.02 (SD = 0.62). These 
mean scores are similar to those reported in the original validation study that had a larger sample 
size [33]. 
3.2. Primary Analysis 
See Table 3 for the results of the multivariate linear regression analyses testing the association 
between the fatty acid composite variables and the three primary temperament dimensions of the 
IBQ-R. These analyses revealed that only higher levels of n-3 PUFA levels predicted lower scores on 
the negative affectivity dimension (see Figure 1). This association remained statistically significant 
after adjustment for the total milk fat content (β = −0.443, p = 0.023) and when all covariates were 
removed from the model (β = −0.335, p = 0.015). In addition, controlling for the time of day of the milk 
collection did not change the significant association between n-3 fatty acids and negative affectivity. 
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Table 3. The association between the milk fatty acid composition and the infant temperament 
assessed with multivariate linear regression models. 
 Negative Affectivity 
Orienting 
/Regulation 
Surgency/Extraversion 
 
Standardized β 
(p-value) 
Standardized β 
(p-value) 
Standardized β 
(p-value) 
Omega-3 −0.352 (0.020) * −0.014 (0.927) −0.108 (0.479) 
Omega-6 −0.249 (0.106) 0.131 (0.394) 0.053 (0.727) 
Omega-6/3 ratio 0.134 (0.387) 0.159 (0.297) 0.179 (0.236) 
Total PUFAs −0.266 (0.083) 0.127 (0.408) 0.042 (0.784) 
Total Milk Fat −0.124 (0.401) −0.004 (0.981) −0.039 (0.791) 
Note: All coefficients are statistically adjusted for the maternal age, mother’s marital status, and infant 
birth weight. * p < 0.05. 
Figure 1. The scatterplot of the total omega-3 fatty acids in the milk and the infant negative affectivity. 
Because the milk n-3 PUFA levels predicted a negative affectivity, we performed a follow-up 
analysis to test how the n-3 PUFAs predicted each of the four subscales that comprised this dimension 
of the IBQ-R. Higher n-3 PUFAs were associated with less sadness (β = −0.349, p = 0.021) and less 
distress to limitations (β = −365, p = 0.017). Milk n-3s were not significantly related to infant fear (β = 
−0.187, p = 0.219) or falling reactivity (β = −0.087, p = 0.584), although these effects were in the same 
direction as those observed for sadness and limitations to distress.  
In addition, given that n-3 PUFAs predicted negative affectivity, we tested whether specific 
subtypes of n-3 PUFAs (ALA, EPA, DHA, or ETE) were, independently, related to negative 
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affectivity. Mothers with higher ALA in their milk reported that their infants had significantly less 
negative affectivity (β = −0.368, p = 0.015). Although they did not reach the criterion for statistical 
significance, the DHA, EPA, and ETE levels were all negatively associated with negative affectivity 
(DHA: β = −0.178, p = 0.229; EPA: β = −0.251, p = 0.095; ETE: β = −0.103, p = 0.472). Moderation Analysis 
Neither the infant sex, nor the breastfeeding exclusivity, significantly moderated the association 
between the milk n-3 PUFA levels and negative affectivity (sex: β = −0.170, p = 0.780; breastfeeding 
exclusivity: β = 0.975, p = 0.071).  
4. Discussion 
The present study found evidence to support a link between the n-3 PUFA composition of 
human milk and infant temperament. Specifically, infants whose mothers had higher levels of n-3 
PUFAs in their milk were reported to display lower levels of negative affectivity at 3 months than 
did infants whose mothers had lower levels of n-3 PUFAs in their milk. To the extent that negative 
affectivity in infancy is associated with a higher risk for internalizing disorders in later childhood 
[39,40], n-3 PUFAs in milk may represent a novel developmental origins pathway through which 
environmental exposures influence the risk for later mental health disorders. To our knowledge, this 
is the first study to report an association between the variation in the n-3 PUFAs levels in milk and 
the temperament in humans. One previous study did report that there was no difference in the 
temperaments of infants who were randomly assigned to receive formula supplemented with DHA 
(vs. non-DHA-supplemented formula) [41] (see [42] for similar null results with rhesus macaques). 
However, formula supplementation studies are not directly comparable to studies of human milk, 
since n-3 PUFAs are metabolized differently in human milk than they are in formula [43], and since 
the absorption of fatty acids from formula is highly dependent on the specific type of oil from which 
the n-3s were harvested [44]. Still, the results of this study should be considered preliminary until 
they can be replicated in larger studies.  
There are several potential physiological pathways through which n-3 PUFAs in milk could 
influence infant affect regulation and temperament. Most directly, n-3 PUFAs and their derivatives 
help to regulate neurotransmission, and animal studies suggest that deficiencies increase the 
serotonin 2 (5-HT2) and decrease dopamine 2 (D2) receptor density in the frontal cortex [45]. The 
upregulation of 5-HT2 and downregulation of D2 in the brain have been implicated in mood disorders 
[46]. Less directly, n-3 PUFAs might influence infant negative affectivity through inflammatory 
pathways [18,19,47]. n-3 PUFAs, and EPA especially, have anti-inflammatory properties and reduce 
the levels of pro-inflammatory cytokines [18,19,47]. In adults, we know from animal and human 
experimental studies that pro-inflammatory cytokines can readily cross the blood–brain barrier and 
induce sickness behavior characterized by depressive-like symptoms such as low mood, social 
withdrawal, and anxiety [48]. The extent to which n-3s PUFAs regulate inflammatory processes in 
early development is unknown, but future research could investigate if n-3 PUFAs’ levels in milk are 
related to inflammatory processes in infants and if, by doing so, they indirectly influence negative 
affectivity.  
It was notable that, of the three primary types of n-3 PUFAs in milk, only higher levels of ALA 
were significantly associated with negative affectivity. The DHA and EPA levels were also inversely 
correlated with negative affectivity, but not to a statistically significant degree. It would be premature 
for readers to conclude, however, that only ALA (and not DHA or EPA) in milk influences infant 
temperament given that all three of the primary n-3 PUFAs were negatively correlated with negative 
affectivity, with effect sizes in the small-to-medium range. Future studies that combine the methods 
used here with direct assessments of infants’ plasma levels of ALA, DHA, and EPA are necessary to 
address the question of whether it is n-3 PUFAs in general, or one subtype of n-3 PUFA in particular, 
that influences infant temperament.  
In their strongest form, these results could have several potential policy implications. First, the 
maternal diet can influence the levels of n-3 PUFAs in milk and, by doing so, may influence infant 
temperament. For example, breast milk EPA and DHA concentrations are closely linked to maternal 
dietary EPA and DHA intake [49], and randomized control trials have shown that mothers given n-
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3 PUFA supplements show corresponding increases in the n-3 PUFA composition of their milk 
[50,51]. Unfortunately, this study did not include information on maternal diets, and only two 
mothers in our study reported taking omega-3 PUFA supplements, so we were not able to test this 
hypothesis. Future studies could examine whether increasing the dietary intake of n-3 PUFAs in 
breastfeeding women would lead to a reduced negative affectivity in infants. Second, considering 
that negative affectivity in infancy predicts internalizing disorders (i.e., anxiety/depression) in later 
childhood [39,40], perhaps supplementing breastfeeding mothers with n-3 PUFAs could help 
ameliorate the risk for later mental health problems. While this possibility is only hypothetical, 
maternal diets during pregnancy and lactation are modifiable and present promising targets for the 
prevention of adverse developmental outcomes in children [52,53]. 
Although this study had several strengths, including the direct assessment of the fatty acid 
composition of milk and the carefully characterized cohort, these results should be considered in the 
context of several limitations. First, we relied on maternal reports of infant temperament, which may 
be biased. Despite this, the IBQ-R has in previous studies been found to correlate highly with more 
objective measures of infant temperament (e.g., behavioral observations) [36]. Moreover, the 
association between the reports of mothers and other caregivers is generally high [33]. Still, future 
research would benefit from including additional object measures of infant temperament and 
behavior. Second, this study was correlational and cannot rule out the possibility that a confounding 
factor may explain the observed association between the n-3 PUFA levels in milk and infant 
temperament. To address this possibility, we tested whether a number of demographic (e.g., income, 
education) and health (e.g., maternal BMI, weight gain in pregnancy) factors predicted the fatty acid 
composition of milk. Only the marital status, maternal age, and infant birth weight predicted the fatty 
acid composition of milk, and statistically adjusting for these covariates did not negate the association 
between n-3 PUFA levels and negative affectivity in this study. Regardless, there are numerous bio-
active factors in milk, such as cortisol, which have been shown to correlate with total milk fat [54] 
and negative affectivity in infants [26]. However, given that we found no association between the 
total fat or n-6 fatty acid content of milk and infant temperament, we believe that the n-3 composition 
of milk and cortisol levels in milk likely represent distinct lactational programming pathways. 
Furthermore, the association between n-3 PUFA levels in milk and negative affectivity remains 
statistically significant after adjusting for the total fat content of the milk, suggesting that it is n-3 
PUFAs specifically, and not richer milk generally, that shapes infant temperament. Finally, this study 
did not include information on the last time mothers had breastfed or on the total milk volume that 
mothers expressed. We were unable to identify any studies that tested how the time since the last 
feeding or the volume of milk production impacts the omega-3 fatty acid composition of milk. Future 
research is needed to determine whether these factors are associated with LC PUFAs and could 
therefore have influenced these results.  
Findings from this study add to the growing body of research demonstrating that the variation 
in the composition of mothers’ milk plays an important role in shaping the development of offspring. 
Specifically, we found that milk that was richer in n-3 PUFAs was associated with reduced sadness 
and distress in infants. These new data are consistent with previous research linking n-3 PUFAs to 
an improved mood and mental health in adults [18–22]. We hope that the exciting research taking 
place in the field of lactational programming will open up new possibilities for preventing mood 
disturbances.  
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